Advance Access published December 12, 2002
|
|
- Drusilla Chase
- 6 years ago
- Views:
Transcription
1 Advance Access published December 12, 2002 Journal of Antimicrobial Chemotherapy DOI: /jac/dkg035 Pharmacokinetic aspects of levofloxacin 500 mg once daily during sequential intravenous/oral therapy in patients with lower respiratory tract infections Mario Furlanut 1, Loris Brollo 1, Emilio Lugatti 2, Elena Di Qual 1, Flavio Dolcet 2, Giovanni Talmassons 2 and Federico Pea 1 * 1 Institute of Clinical Pharmacology and Toxicology, Department of Experimental and Clinical Pathology and Medicine, Medical School, University of Udine, P.le S. Maria della Misericordia 3, Udine; 2 Division of Pneumology, S. Maria della Misericordia Hospital, Udine, Italy Introduction Received 2 August 2002; returned 10 September 2002; revised 25 September 2002; accepted 3 October 2002 Levofloxacin is considered an effective antibiotic in the treatment of community-acquired lower respiratory tract infections (LRTIs). A study was carried out on 17 in-patients to assess the pharmacokinetics of a 500 mg once-daily switch intravenous (iv)/oral regimen of levofloxacin in the treatment of LRTI patients. Blood samples were collected under steady-state conditions at appropriate intervals. Levofloxacin plasma concentrations were analysed by means of HPLC and pharmacokinetic parameters were estimated using the WinNonlin pharmacokinetic software package. A lower clearance of levofloxacin (<2 ml/min/kg), conditioning both a longer elimination half-life ( 9 h) and a larger AUC 0 τ ( 80 mg/l h), was observed for both routes in our patients than in healthy volunteers. These differences may be explained considering that levofloxacin is excreted mainly as unchanged drug by the renal route, and most of our patients (71%) were very elderly subjects whose renal function physiologically declines with age. The almost complete ( 99%) absolute oral bioavailability suggests that a comparable exposure to the iv regimen may be achieved after oral administration. The overall clinical success rate was 94.1%. Keywords: levofloxacin, oral bioavailability, switch therapy, elderly Levofloxacin is characterized by rapid bactericidal activity and a broad antimicrobial spectrum, which make it an attractive agent for the treatment of community-acquired lower respiratory tract infections (LRTIs). 1 5 Unlike earlier fluoroquinolones, levofloxacin is active not only against many Gram-negative aerobic species (i.e. Moraxella catharralis, Haemophilus influenzae and Enterobacteriaceae), 6 but also against the major Gram-positive aerobic microorganisms implicated in LRTIs, namely Streptococcus pneumoniae (including penicillin-resistant strains) 7 and methicillinsusceptible Staphylococcus aureus (MSSA). 1,6 A population pharmacokinetic study in healthy volunteers showed that oral levofloxacin may achieve a higher level in the epithelial lining fluid than in plasma (1.16-fold), this exposure guaranteeing optimal efficacy against the extracellular pathogens involved in LRTIs. 8 Moreover, thanks to its ability to penetrate the plasma membrane of eukaryotic cells, levofloxacin also exhibits a valid activity against intracellular pathogens responsible for atypical pneumonia, namely Mycoplasma pneumoniae, Legionella pneumophila and Chlamydia pneumoniae In a randomized prospective multicentre trial, File et al. 12 showed that intravenous (iv) and/or oral levofloxacin 500 mg once daily for 7 14 days was more effective than iv ceftriaxone 1 2 g once or twice daily and/or oral cefuroxime axetil... *Corresponding author. Tel/Fax: ; federico.pea@med.uniud.it... Page 1 of The British Society for Antimicrobial Chemotherapy
2 M. Furlanut et al. 500 mg twice daily ± oral erythromycin g four times a day in the treatment of 590 patients with community-acquired pneumonia (96% versus 90% clinical success). Likewise, a 500 mg once-daily dose of levofloxacin was shown to be effective in the treatment of both acute exacerbation of chronic bronchitis 13 and community-acquired pneumonia sustained by macrolide-resistant S. pneumoniae. 14 On this basis, levofloxacin may be considered an effective alternative choice to the β-lactam plus macrolide combination in the empirical treatment of community-acquired LRTIs especially when an intracellular pathogen may be involved or when a high rate of penicillin- or macrolide-resistant S. pneumoniae or an allergy to β-lactams may be the concern Since levofloxacin may be administered either parenterally or orally, a sequential timely conversion from iv to oral therapy may be adopted for enabling both a cost-effective treatment of infections and an early hospital discharge. 19 The primary objective of our study was to assess the pharmacokinetic appropriateness and the interindividual variability of a standard switch iv/oral regimen of levofloxacin 500 mg once daily frequently used in routine clinical practice for the treatment of patients with LRTIs. Patients and methods Study entry criteria This study was carried out on a cohort of 17 in-patients (10 male and seven female) empirically treated for LRTIs (communityacquired pneumonia or acute exacerbation of chronic bronchitis) at the Division of Pneumology, SM Misericordia Hospital, Udine, Italy. All the patients were treated with a standard levofloxacin regimen, irrespective of their body weight, sex and age, for a variable duration according to the clinical status: 500 mg iv once daily administered as a 1 h intermittent infusion for 4 9 days followed by 500 mg oral once daily until the end of the therapy (total duration of therapy being 9 17 days). Patients characteristics are depicted in Table 1. No patient presented with major renal or hepatic impairment. The aetiological agents were assessed by cultures of sputum and, whenever isolated, their in vitro susceptibility to levofloxacin was tested. The MIC was determined according to NCCLS methods. Study design The pharmacokinetic evaluations of levofloxacin were carried out after having obtained an informed consent from each patient. Criteria for inclusion in the study were: age 18 years, serum creatinine < 1.5 mg/dl, antimicrobial monotherapy with levofloxacin. The iv and oral pharmacokinetic evaluations were carried out under steady-state conditions, that is after at least 48 h of unmodified treatment by each route of administration. To avoid potential interactions, 20,21 patients were fasted overnight before and for 3 h after levofloxacin morning administration and no antacid drugs were co-administered during the study period. Many of the patients were co-treated with other drugs, none of which had a known influence on levofloxacin pharmacokinetics. Blood samples were collected each time by direct venal puncture: before and 0, 0.25, 0.5, 1, 2, 4, 6, 8 and 11 h after the 1 h iv infusion; before and 0.5, 1, 1.5, 2, 4, 6, 8 and 12 h after the oral administration. All the samples were frozen at 80 C until assayed. HPLC analysis Table 1. Patient characteristics at baseline Parameter CL CR, estimated creatinine clearance by means of the Cockcroft and Gault formula; 28 SCr, serum creatinine (normal range = mg/dl); SGOT, serum glutamic oxalacetic transaminase (normal range = IU/L); SGPT, serum glutamic pyruvic transaminase (normal range = IU/L). Levofloxacin plasma concentrations were analysed by means of an HPLC method validated in our laboratory, as previously described. 22,23 This method was not stereospecific for levofloxacin in the presence of ofloxacin; however, since levofloxacin has been shown to be stereochemically stable and not to convert into ofloxacin in vivo, this did not interfere with the assay. 24,25 Intra- and inter-assay coefficients of variation (CV) were always <10%. The lower limit of detection was 0.1 mg/l. Pharmacokinetic evaluations Mean ± S.D. Age (years) 70 ± 13 Gender 10 M/7 F Weight (kg) 71 ± 15 SGOT (IU/L) 31 ± 20 SGPT (IU/L) 51 ± 35 SCr (mg/dl) 0.98 ± 0.26 CL CR (ml/min/kg) 1.03 ± 0.40 Individual patient s concentration-versus-time data obtained were estimated by a two-compartment open model with firstorder elimination using the WinNonlin pharmacokinetic software package (Pharsight Corporation, Mountain View, CA, USA). The pharmacokinetic parameters assessed after iv administration included: steady-state maximum plasma concentration (C max ss ), volume of distribution at the steadystate (V ss ), distribution half-life (t 1/2 α), elimination half-life (t 1/2 β), total body clearance (CL) and area under the plasma concentration time curve during the observational period (AUC 0 τ ). The pharmacokinetic parameters explored after Page 2 of 6
3 oral administration included: C max ss, time to reach maximum plasma concentration (T max ), V ss, absorption half-life (t 1/2 k a ), t 1/2 α, t 1/2 β, CL and AUC 0 τ. The absolute oral bioavailability (F os ) was determined by means of the following formula: [AUC po (0 τ) /AUC iv (0 τ) ] 100. Since patients received standard levofloxacin dosages, to avoid bias due to interindividual differences in body weight, the dose-related pharmacokinetic parameters (C max ss and AUC 0 τ ) were also normalized with respect to levofloxacin dose per kg, and consequently to a dose of 1 mg/kg levofloxacin every 24 h. Levofloxacin switch therapy in patients with LRTIs Assessment of clinical efficacy The clinical efficacy of the antimicrobial therapy was defined as follows. Cure was defined as complete resolution of clinically significant signs and symptoms of LRTI at the end of therapy; improvement was defined as partial resolution of clinically significant signs and symptoms of LRTI at the end of therapy; failure was defined as the need for a change in therapy during treatment because of the persistence or worsening of clinical symptoms of LRTI. Cure and improvement were considered as successful responses. Statistical analysis According to normal or non-normal distribution, the findings were expressed as mean ± standard deviation (S.D.) or median and range, respectively. Statistical analysis was carried out by t-test for paired data and/or Mann Whitney Rank Sum Test as appropriate using SigmaStat (Jandel Scientific, GmbH, Erkrath, Germany). A statistically significant difference was defined as P < Results Patients characteristics and microbiology Among the 17 patients included in the study, admission diagnosis was acute exacerbation of chronic bronchitis in 10 cases and pneumonia in seven cases. Despite appropriate microbial investigations, only five of these 17 LRTI patients (29%) had a microbiologically confirmed bacterial aetiology. The infection was monomicrobial in three cases (Enterococcus spp., Pseudomonas aeruginosa, methicillin-susceptible S. aureus) and polymicrobial in two cases (Enterobacter aerogenes, H. influenzae and S. pneumoniae in one case; H. influenzae and Klebsiella pneumoniae in the other case). All of these isolates were shown to be sensitive in vitro to levofloxacin (MIC < 1 mg/l). Pharmacokinetic analysis Mean (± standard deviation, S.D.) levofloxacin plasma concentration-versus-time profiles after both iv and oral Figure 1. Mean (±S.D.) steady-state levofloxacin plasma concentration time profiles following iv and oral administration of 500 mg once daily during sequential therapy in LRTI patients (n = 17). Figure 2. Relationship between steady-state levofloxacin plasma clearance (CL) and estimated creatinine clearance (CL CR ) by means of the Cockcroft and Gault formula. 28 administration are shown in Figure 1. Average levofloxacin C max ss was mg/l immediately after the 1 h iv infusion and 7.93 mg/l at 1.23 h after oral administration, respectively. Levofloxacin pharmacokinetic parameters are summarized in Table 2. Moderate linear relationships between estimated creatinine clearance, on the one hand, and either levofloxacin CL (Figure 2) or dose-normalized AUC 0 τ (Figure 3), on the other hand, were observed. Dose-normalized data showed that for each mg/kg of levofloxacin, the mean dose-normalized C max ss reached was 1.46 and 1.22 mg/l, whereas the mean fractional AUC 0 τ guaranteed was and mg/l h, for the iv and oral route, respectively. Page 3 of 6
4 M. Furlanut et al. Table 2. Mean ± S.D. steady-state levofloxacin pharmacokinetic parameters after iv and oral administration of 500 mg once daily during sequential therapy in 17 patients with LRTIs Route of administration Parameter iv oral P value Dose 0 τ (mg/kg/24 h) 7.46 ± ± C max ss (mg/l) ± ± T max (h) NA 1.23 ± 0.71 NA V ss (L/kg) 1.24 ± ± t 1/2 k a (h) NA 0.29 ± 0.16 NA t 1/2 α (h) 0.27 ± ± t 1/2 β (h) 8.77 ± ± CL (ml/min/kg) 1.87 ± ± AUC 0 τ (mg/l h) ± ± F os (%) NA 114 ± 19 NA Dose-normalized C max ss (mg/l per mg/kg) 1.46 ± ± Dose-normalized AUC 0 τ (mg/l h per mg/kg) ± ± AUC 0 τ = area under the plasma concentration time curve during the observation period; CL = total body clearance; C max ss = steadystate peak plasma concentration; Dose 0 τ = amount of dose every 24 h; F os = percentage absolute oral bioavailability; NA = not applicable; t 1/2 α = distribution half-life; t 1/2 β = elimination half-life; t 1/2 k a, absorption half-life; T max, time to reach C max ; V ss, volume of distribution at the steady-state. Outcome of therapy Clinical outcome. Median length of levofloxacin therapy was 5 and 6 days for iv and oral treatment, respectively. At the end of levofloxacin therapy, the overall clinical success rate was 94.1%, since 76.4% (13/17) of cases were cured, whereas 17.6% of cases (3/17) were improved. In the remaining 5.9% of cases (1/17), the therapy failed and, consequently led to a persistence of clinical symptoms of LRTI; a change in the Figure 3. Relationship between steady-state dose-normalized levofloxacin area under the concentration time curve (AUC 0 τ ) and estimated creatinine clearance (CL CR ) by means of the Cockcroft and Gault formula. 28 antimicrobial chemotherapy (ceftazidime plus ciprofloxacin plus amikacin) was required. Discussion Our study compared the steady-state pharmacokinetic profile of a standard levofloxacin 500 mg once-daily regimen during a switch iv/oral therapy and assessed clinical outcome in LRTI patients. Although our pharmacokinetic data were generally similar to those observed by other authors, a lower clearance, conditioning both a longer elimination half-life and a larger AUC, was observed after both administration routes in our patients than in healthy volunteers These differences may be explained considering that levofloxacin is mainly excreted as unchanged drug by the kidney, and most of our patients were very elderly subjects (12/17 aged >71 years) whose renal function had physiologically declined with age, as definitely demonstrated by Cockcroft & Gault. 28 Tanigawara et al. 29 in a premarketing population pharmacokinetic study found that the elderly exhibited a 32% reduction in levofloxacin clearance as a consequence of a lower creatinine clearance. Likewise, Chien et al. 30 showed that levofloxacin clearance after administration of a single 500 mg oral dose was significantly lower in elderly than in young volunteers (1.68 versus 2.49 ml/min/kg) mainly due to major differences in renal function. According to this hypothesis, a moderate linear relationship between levofloxacin clearance and creatinine clearance after both iv and oral administration was also found in our study. Page 4 of 6
5 Levofloxacin switch therapy in patients with LRTIs As a consequence of this reduced clearance, total body exposure to levofloxacin (AUC 0 τ ) was 1.5-fold larger in our patients than in young healthy volunteers, but it was comparable to Chien s findings in elderly volunteers. 30 Normalized data showed that a wide interindividual variability for C max and AUC 0 τ persists irrespective of patient body weight (coefficient of variations between 25% and 41%). This is in agreement with other authors findings showing that interindividual variation in levofloxacin pharmacokinetics may largely be related to the estimated creatinine clearance either in patients with serious community-acquired infection 31 or in ICU patients with early onset ventilator-associated pneumonia. 23 In particular, in a population pharmacokinetic study, Preston et al. 31 showed that the most important covariate influencing the clearance of levofloxacin in 272 patients with community-acquired infection was the estimated creatinine clearance. Although iv levofloxacin should be considered the optimal route for initial empirical therapy in hospitalized patients with serious LRTIs, the oral route may represent both an effective and cost saving regimen in appropriately selected patients, namely from the commencement in mild to moderate LRTI outpatients or as a continuation therapy. An oral 500 mg once-daily levofloxacin regimen should be considered a valid therapeutic approach for LRTIs in malabsorption-free patients, since it provides an effective treatment at lower costs. 19 However, other less expensive treatments based on β-lactams (i.e. cefuroxime) and macrolides (i.e. clarithromycin) may also represent a valid alternative for the sequential iv/oral therapy of LRTIs, especially when a risk factor for fluoroquinolone use exists (i.e. neurological disorders). The almost complete ( 99%) absolute oral bioavailability and the mean oral C max ss quite similar to that observed immediately after the 1 h iv infusion (7.93 versus mg/l) suggest that a comparable exposure to the iv regimen may be achieved after oral administration of levofloxacin. The >100% average oral bioavailability (114%) suggests that a larger exposure for the oral than for the iv route might have occurred in some cases. Actually, since this was a withinpatient study and the same dosage was administered for both routes, these results might have represented a hard-to-explain finding. However, it has to be considered that Chien et al., 26 in a cross-over 500 mg iv versus oral single dose study assessing levofloxacin pharmacokinetics in 23 healthy volunteers, showed that the oral bioavailability of levofloxacin was of a similar extent (103 ± 10%). Moreover, in our patients the trend for a larger exposure after the oral route may be partially explained by the fact that a slight reduction in renal function was observed in some patients during the oral assessment. As a consequence, a mean 12% lower levofloxacin clearance (1.65 versus 1.87 ml/min/kg) leading to an 1.15-fold longer average elimination half-life of levofloxacin (9.81 versus 8.77 h) was observed after oral compared with iv administration. In any case, no statistically significant difference between mean AUCs (both for absolute and normalized data) was observed after oral and iv administration of levofloxacin. A successful clinical response was obtained in all but one patient (94%), in agreement with other authors findings showing that iv/oral therapy with levofloxacin 500 mg once daily was very effective (96% clinical success) in treating community-acquired pneumonia. 12 Whereas the median duration of therapy was in line with many guidelines for LRTIs, in two cases it was decided to prolong treatment for 14 and 17 days, respectively, due to the severity of illness. In conclusion, the switch iv/oral levofloxacin 500 mg once-daily therapy represents a valid approach in the treatment of LRTIs. The concentration-dependent pharmacodynamic bactericidal activity combined with the sufficiently long elimination half-life of levofloxacin justifies the oncea-day administration in patients with community-acquired LRTIs. Acknowledgements We would like to thank Dr Orietta Coletti for her valuable help and Mrs Eliana Di Terlizzi for her technical assistance. Aspects of this work were partially presented in abstract form at the Fourth European Congress of Chemotherapy and Infection, Paris, France, 4 7 May References 1. Langtry, H. D. & Lamb, H. M. (1998). Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract. Drugs 56, Norrby, S. R. (2001). Optimal treatment strategies for acute exacerbations of chronic bronchitis: high-risk patients. Chemotherapy 47, Carbon, C. (2001). Optimal treatment strategies for communityacquired pneumonia: high-risk patients (geriatric and with comorbidity). Chemotherapy 47, File, T. M., Jr (2001). Optimal treatment strategies for community-acquired pneumonia: non-responders to conventional regimens. Chemotherapy 47, Shah, P. M. (2000). The use of levofloxacin in the treatment of respiratory tract infection. Journal of Chemotherapy 12, Yamane, N., Jones, R. N., Frei, R., Hoban, D. J., Pignatari, A. C. & Marco, F. (1994). Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin. Journal of Chemotherapy 6, Jones, R. N. & Pfaller, M. A. (2000). In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program. Clinical Infectious Diseases 31, S Drusano, G. L., Preston, S. L., Gotfried, M. H., Danziger, L. H. & Rodvold, K. A. (2002). Levofloxacin penetration into epithelial Page 5 of 6
6 M. Furlanut et al. lining fluid as determined by population pharmacokinetic modeling and monte carlo simulation. Antimicrobial Agents and Chemotherapy 46, Jonas, D., Engels, I., Friedhoff, C., Spitzmuller, B., Daschner, F. D. & Frank, U. (2001). Efficacy of moxifloxacin, trovafloxacin, clinafloxacin and levofloxacin against intracellular Legionella pneumophila. Journal of Antimicrobial Chemotherapy 47, Hammerschlag, M. R. & Roblin, P. M. (2000). Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae. Antimicrobial Agents and Chemotherapy 44, Critchley, I. A., Jones, M. E., Heinze, P. D., Hubbard, D., Engler, H. D., Evangelista, A. T. et al. (2002). In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe. Clinical Microbiology and Infection 8, File, T. M., Jr, Segreti, J., Dunbar, L., Player, R., Kohler, R., Williams, R. R. et al. (1997). A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia. Antimicrobial Agents and Chemotherapy 41, Masterton, R. G. & Burley, C. J. (2001). Randomized, doubleblind study comparing 5- and 7-day regimens of oral levofloxacin in patients with acute exacerbation of chronic bronchitis. International Journal of Antimicrobial Agents 18, Fogarty, C. M., Greenberg, R. N., Dunbar, L., Player, R., Marrie, T. J., Kojak, C. M. et al. (2001). Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolideresistant Streptococcus pneumoniae: integrated results from four open-label, multicenter, phase III clinical trials. Clinical Therapeutics 23, Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Jr, Musher, D. M. & Fine, M. J. (2000). Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clinical Infectious Diseases 31, Mandell, L. A., Marrie, T. J., Grossman, R. F., Chow, A. W. & Hyland, R. H. (2000). Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clinical Infectious Diseases 31, Niederman, M. S., Mandell, L. A., Anzueto, A., Bass, J. B., Broughton, W. A., Campbell, G. D. et al. (2001). Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. American Journal of Respiratory and Critical Care Medicine 163, Zhanel, G. G., Ennis, K., Vercaigne, L., Walkty, A., Gin, A. S., Embil, J. et al. (2002). A critical review of the fluoroquinolones: focus on respiratory infections. Drugs 62, Milkovich, G. (2001). Intravenous-to-oral transition therapy in community-acquired pneumonia: the INOVA Health System experience. Pharmacotherapy 21, 83S 88S. 20. Lee, L. J., Hafkin, B., Lee, I. D., Hoh, J. & Dix, R. (1997). Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjects. Antimicrobial Agents and Chemotherapy 41, Pea, F. & Furlanut, M. (2001). Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions. Clinical Pharmacokinetics 40, Scotton, P. G., Pea, F., Giobbia, M., Baraldo, M., Vaglia, A. & Furlanut, M. (2001). Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis. Clinical Infectious Diseases 33, e Pea, F., Di Qual, E., Cusenza, A., Brollo, L., Baldassarre, M. & Furlanut, M. (2002). Pharmacokinetics and pharmacodynamics of levofloxacin 500 mg bid IV in ICU patients with early-onset ventilator-associated pneumonia. Clinical Pharmacokinetics, in press. 24. Verho, M., Malerczyk, V., Damm, D. & Lehr, K. H. (1996). Pharmacokinetics of levofloxacin in comparison to the racemic mixture of ofloxacin in man. Drug Metabolism and Drug Interaction 13, Fish, D. N. & Chow, A. T. (1997). The clinical pharmacokinetics of levofloxacin. Clinical Pharmacokinetics 32, Chien, S. C., Rogge, M. C., Gisclon, L. G., Curtin, C., Wong, F., Natarajan, J. et al. (1997). Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses. Antimicrobial Agents and Chemotherapy 41, Lubasch, A., Keller, I., Borner, K., Koeppe, P. & Lode, H. (2000). Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers. Antimicrobial Agents and Chemotherapy 44, Cockcroft, D. W. & Gault, M. H. (1976). Prediction of creatinine clearance from serum creatinine. Nephron 16, Tanigawara, Y., Nomura, H., Kagimoto, N., Okumura, K. & Hori, R. (1995). Premarketing population pharmacokinetic study of levofloxacin in normal subjects and patients with infectious diseases. Biological and Pharmaceutical Bulletin 18, Chien, S. C., Chow, A. T., Natarajan, J., Williams, R. R., Wong, F. A., Rogge, M. C. et al. (1997). Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects. Antimicrobial Agents and Chemotherapy 41, Preston, S. L., Drusano, G. L., Berman, A. L., Fowler, C. L., Chow, A. T., Dornseif, B. et al. (1998). Levofloxacin population pharmacokinetics and creation of a demographic model for prediction of individual drug clearance in patients with serious communityacquired infection. Antimicrobial Agents and Chemotherapy 42, Page 6 of 6
How long does levofloxacin take to work for pneumonia
How long does levofloxacin take to work for pneumonia Who should not take Levofloxacin? Show More.. Drug interactions may change how your medications work or increase your risk. Does Levofloxacin interact
More informationthe primary study, received the booster dose of 10Pn-PD-DiT co-administered with DTPa-HBV-IPV/Hib
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationSCIENTIFIC DISCUSSION
This part reflects the scientific knowledge and the information about this product available at the time of prequalification. Thereafter, updates may have become necessary which are included in parts 1
More informationAqueous and Vitreous Penetration of Linezolid and Levofloxacin After Oral Administration
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS Volume 26, Number 6, 2010 ª Mary Ann Liebert, Inc. DOI: 10.1089/jop.2010.0022 Aqueous and Vitreous Penetration of Linezolid and Levofloxacin After Oral Administration
More informationProficiency Testing FINAL REPORT Check sample program 16CSP02 February 2016
Proficiency Testing FINAL REPORT Check sample program 16CSP2 February 216 Proficiency Testing Provider Certificate Number 3189-2. Program Coordinator: Ingrid Flemming IFM Quality Services Pty Ltd PO Box
More informationQuantitative Analysis of the Adapted Physical Education Employment Market in Higher Education
Quantitative Analysis of the Adapted Physical Education Employment Market in Higher Education by Jiabei Zhang, Western Michigan University Abstract The purpose of this study was to analyze the employment
More informationATM Network Performance Report
ATM Network Performance Report 2019 Page 1 of 20 Table of contents Summary... 3 Network Wide Performance... 4 Airborne delay... 4 Sydney... 7 Airborne delay... 7 Notable events... 7 CTOT (Calculated take
More informationLevofloxacin its practical application in the treatment and pharmacokinetics
1 FARMACJA WSPÓŁCZESNA 2016; 9: 1-7 Akademia Medycyny ARTYKUŁ POGLĄDOWY/REVIEW PAPER Otrzymano/Submitted: 11.02.2016 Zaakceptowano/Accepted: 11.03.2016 Levofloxacin its practical application in the treatment
More informationPage 1 of 52. Duration (days) 24 hours 250 mg/dose) Plague (1.14) Adults and Pediatric Patients > 50 kg
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LEVOFLOXACIN TABLETS safely and effectively. See full prescribing information for LEVOFLOXACIN TABLETS.
More informationDate Camper Name: LAST, FIRST (Please print) Medical Form
Date Camper Name: LAST, FIRST (Please print) Medical Form Medical information must be provided for you or your child to attend camp. To ensure the health and safety of our volunteer staff, adult and youth
More informationSarah F. Smith, B. Sc. February, 2001
INFLUENCES ON THE INCIDENCE OF CLINICAL DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM IN A PROSPECTIVELY COLLATED POPULATION OF 21,000 NEUROSURGICAL INPATIENTS Sarah F. Smith, B. Sc. February, 2001 This
More informationIs Occupation as Air Transport Pilot a Stroke Risk?
Dr Kevin Tan Is Occupation as Air Transport Pilot a Stroke Risk? A Case-Control Study Why this question? Why? Shift & Night Work Sleep Restriction Air Transport Pilot Occupation? Ischaemic Stroke 4% increased
More informationUNITED STATES DEPARTMENT OF AGRICULTURE FOOD SAFETY AND INSPECTION SERVICE WASHINGTON, DC
UNITED STATES DEPARTMENT OF AGRICULTURE FOOD SAFETY AND INSPECTION SERVICE WASHINGTON, DC FSIS NOTICE 05-09 1/7/09 MEASURES TO ADDRESS E. coli O157:H7 AT ESTABLISHMENT THAT RECEIVE, GRIND, OR OTHERWISE
More informationAnti-Bacterial Foam Soap
For everyday use. Vectair Sanitex MVP Anti-Bacterial Foam Soap For everyday use. Our Anti-Bacterial Foam Soap for the Vectair Sanitex MVP Manual Dispenser is a foaming antibacterial product for everyday
More informationImpact of Landing Fee Policy on Airlines Service Decisions, Financial Performance and Airport Congestion
Wenbin Wei Impact of Landing Fee Policy on Airlines Service Decisions, Financial Performance and Airport Congestion Wenbin Wei Department of Aviation and Technology San Jose State University One Washington
More informationSolid waste generation and disposal by Hotels in Coimbatore City
Solid waste generation and disposal by Hotels in Coimbatore City Donald M. Ephraim Research Scholar, Bharathiyar University, Coimbatore, India S. Boopathi Reader, Bharathiyar University, Coimbatore, India
More informationAirspace Complexity Measurement: An Air Traffic Control Simulation Analysis
Airspace Complexity Measurement: An Air Traffic Control Simulation Analysis Parimal Kopardekar NASA Ames Research Center Albert Schwartz, Sherri Magyarits, and Jessica Rhodes FAA William J. Hughes Technical
More informationSampling for Microbial Analysis
Sampling for Microbial Analysis Linda J. Harris, Ph.D. Department of Food Science and Technology ljharris@ucdavis.edu Microbial Testing One of the most apparent but poorly understood parts of food microbiology
More informationALLOMETRY: DETERMING IF DOLPHINS ARE SMARTER THAN HUMANS?
Biology 131 Laboratory Spring 2012 Name Lab Partners ALLOMETRY: DETERMING IF DOLPHINS ARE SMARTER THAN HUMANS? NOTE: Next week hand in this completed worksheet and the assignments as described. Objectives
More informationProject Summary. Principal Investigators: Lawrence D. Goodridge 1 ; Phil Crandall 2, and Steven Ricke 2. Study Completed 2010
Project Summary Validation of the use of Citrus Essential Oils as a Post Harvest Intervention against Escherichia coli O157:H7 and Salmonella spp. on Beef Carcasses Principal Investigators: Lawrence D.
More informationTowards New Metrics Assessing Air Traffic Network Interactions
Towards New Metrics Assessing Air Traffic Network Interactions Silvia Zaoli Salzburg 6 of December 2018 Domino Project Aim: assessing the impact of innovations in the European ATM system Innovations change
More informationBROMLEY CLINICAL COMMISSIONING GROUP INDIVIDUAL FUNDING REQUESTS ANNUAL REPORT
BROMLEY CLINICAL COMMISSIONING GROUP INDIVIDUAL FUNDING REQUESTS ANNUAL REPORT 2015-2016 AUTHOR: Russell Warrior Contract Manager Responsible for IFR Management TO BE CONSIDERED BY: Bromley Clinical Commissioning
More informationMECHANICAL HARVESTING SYSTEM AND CMNP EFFECTS ON DEBRIS ACCUMULATION IN LOADS OF CITRUS FRUIT
MECHANICAL HARVESTING SYSTEM AND CMNP EFFECTS ON DEBRIS ACCUMULATION IN LOADS OF CITRUS FRUIT RESEARCH REPORT FOR FLORIDA CITRUS HARVESTING RESEARCH ADVISORY COUNCIL FROM TIMOTHY M. SPANN, PH.D. UNIVERSITY
More informationLA PREVENTION EN PRATIQUE
LA PREVENTION EN PRATIQUE COLLECTIVE AND PERSONAL PROTECTIVE EQUIPMENT USED WHEN HANDLING CYTOSTATIC / CYTOTOXIC PRODUCTS La prévention en pratique 30 mai 2017 1 1 CENEXI-LABORATOIRES THISSEN S.A. La prévention
More informationWEEKLY EPIDEMIOLOGICAL REPORT WEST NILE VIRUS INFECTION, GREECE, Aug
HELLENIC CENTRE FOR DISEASE CONTROL AND PREVENTION (HCDCP-KEELPNO) MINISTRY OF HEALTH WEEKLY EPIDEMIOLOGICAL REPORT WEST NILE VIRUS INFECTION, GREECE, 2012-31 Aug. 2012 - This weekly epidemiological report
More informationLaboratories & Consulting Group
Final Report Efficacy of Hypobromous Acid as a Hide Intervention Performed July 18-20, 2011 Submitted to Mike Harvey Technical Operations Mgr. Enviro Tech 500 Winmoore Way Modesto, CA 95358 209-232-2211
More informationBelow are the indication and summary of the most serious and most common risks associated with the use of Benicar and Benicar HCT.
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD 20993 Anthony J. Corrado, Director Commercial Regulatory Affairs Two Hilton Court Parsipanny,
More informationOutbreak of Escherichia coli O157. Connecticut, Quyen Phan, MPH Connecticut Department of Public Health
Outbreak of Escherichia coli O157 Associated with Raw Milk, Connecticut, 2008 Quyen Phan, MPH Connecticut Department of Public Health Epidemiology and Emerging Infections Program 2009 OutbreakNet Annual
More informationDATA-DRIVEN STAFFING RECOMMENDATIONS FOR AIR TRAFFIC CONTROL TOWERS
DATA-DRIVEN STAFFING RECOMMENDATIONS FOR AIR TRAFFIC CONTROL TOWERS Linda G. Pierce FAA Aviation Safety Civil Aerospace Medical Institute Oklahoma City, OK Terry L. Craft FAA Air Traffic Organization Management
More informationAn Econometric Study of Flight Delay Causes at O Hare International Airport Nathan Daniel Boettcher, Dr. Don Thompson*
An Econometric Study of Flight Delay Causes at O Hare International Airport Nathan Daniel Boettcher, Dr. Don Thompson* Abstract This study examined the relationship between sources of delay and the level
More informationAn Exploration of LCC Competition in U.S. and Europe XINLONG TAN
An Exploration of LCC Competition in U.S. and Europe CLIFFORD WINSTON JIA YAN XINLONG TAN BROOKINGS INSTITUTION WSU WSU Motivation Consolidation of airlines could lead to higher fares and service cuts.
More informationHickerson, B., & Henderson, K. A. (2010, May/June). Children s summer camp-based physical activity. Camping Magazine, 83(3),
Children s Summer Camp-Based Physical Activity By: Benjamin Hickerson and Karla Henderson. Hickerson, B., & Henderson, K. A. (2010, May/June). Children s summer camp-based physical activity. Camping Magazine,
More informationAmerican Indian/Alaskan Native Black or African American Hispanic/Latino Asian or Pacific Islander Caucasian/White Mix Other
For Official Use Only: Branch: Camp Site: Camp Group: CHILD S FIRST & LAST NAME ADDRESS (Street Address, Apt#, City, Zip Code) DATE OF BIRTH (Month/Day/Year) CHILD S DISMISSAL [ ] BE PICKED UP [ ]WALK
More informationFIXED-SITE AMUSEMENT RIDE INJURY SURVEY FOR NORTH AMERICA, 2016 UPDATE
FIXED-SITE AMUSEMENT RIDE INJURY SURVEY FOR NORTH AMERICA, 2016 UPDATE Prepared for International Association of Amusement Parks and Attractions Alexandria, VA by National Safety Council Research and Statistical
More informationAboriginal and Torres Strait Islander Life Expectancy and Mortality Trend Reporting
Aboriginal and Torres Strait Islander Life Expectancy and Mortality Trend Reporting Technical Report December 2015 Amended May 2016 Authors: Clare Coleman, Nicola Fortune, Vanessa Lee, Kalinda Griffiths,
More informationTACWA September Meeting CHALLENGES IN MEETING THE TEXAS BACTERIAL LIMITS WITH UV ALONG THE COAST AND BAYS. Gennady Boksiner, P.E. September 30, 2011
TACWA September Meeting CHALLENGES IN MEETING THE TEXAS BACTERIAL LIMITS WITH UV ALONG THE COAST AND BAYS Gennady Boksiner, P.E. September 30, 2011 Bacterial Groups Intestinal bacteria of humans and other
More informationHOW TO IMPROVE HIGH-FREQUENCY BUS SERVICE RELIABILITY THROUGH SCHEDULING
HOW TO IMPROVE HIGH-FREQUENCY BUS SERVICE RELIABILITY THROUGH SCHEDULING Ms. Grace Fattouche Abstract This paper outlines a scheduling process for improving high-frequency bus service reliability based
More informationSCOPE AND PATTERNS OF TOURIST ACCIDENTS IN THE EUROPEAN UNION
SCOPE AND PATTERNS OF TOURIST ACCIDENTS IN THE EUROPEAN UNION Final Report Kuratorium für Schutz und Sicherheit (Austrian Institute for Safety and Prevention) - Institut "Sicher Leben" Injury Prevention
More informationPREFERENCES FOR NIGERIAN DOMESTIC PASSENGER AIRLINE INDUSTRY: A CONJOINT ANALYSIS
PREFERENCES FOR NIGERIAN DOMESTIC PASSENGER AIRLINE INDUSTRY: A CONJOINT ANALYSIS Ayantoyinbo, Benedict Boye Faculty of Management Sciences, Department of Transport Management Ladoke Akintola University
More informationECOLABELLING of Portable Rechargeable Batteries
ECOLABELLING of Portable Rechargeable Batteries RECHARGE s APPROACH 1. OBJECTIVE RECHARGE s objective is to contribute to the development of criteria for the Ecolabelling of Portable Rechargeable Batteries
More informationNotes largely based on. Meeker and L. A. Escobar, Wiley, 1998 and on their class notes. 8/21/2010 Stat 567: Unit 1 - Ramón V.
Unit 1: Reliability Concepts and Reliability Data Notes largely based on Statistical Methods for Reliability Data by WQ W.Q. Meeker and L. A. Escobar, Wiley, 1998 and on their class notes. 8/21/2010 Stat
More informationFigure 1.1 St. John s Location. 2.0 Overview/Structure
St. John s Region 1.0 Introduction Newfoundland and Labrador s most dominant service centre, St. John s (population = 100,645) is also the province s capital and largest community (Government of Newfoundland
More informationTABLE OF CONTENTS. TOURIST EXPENDITURE 31 Average Spend per Person per Night ( ) 31 Tourist Expenditure per Annum ( ) 32
FALKLAND ISLANDS International Tourism Statistics Report 2013 2 3 4 TABLE OF CONTENTS PAGE INTRODUCTION 6 KEY FACTS AND FIGURES 7 INBOUND TOURISM (OVERNIGHT VISITORS) 8 TOURIST ARRIVALS 8 Tourist Arrivals
More informationBacteriological testing of water
MOBILE NOTE 6 Bacteriological testing of water Introduction Bacteriological water testing is a method of collecting water samples and analysing those samples to estimate the numbers of bacteria present.
More informationTodsanai Chumwatana, and Ichayaporn Chuaychoo Rangsit University, Thailand, {todsanai.c;
Using Hybrid Technique: the Integration of Data Analytics and Queuing Theory for Average Service Time Estimation at Immigration Service, Suvarnabhumi Airport Todsanai Chumwatana, and Ichayaporn Chuaychoo
More informationG. Glukhov The State Scientific Research Institute of Civil Aviation, Mikhalkovskaya Street, 67, building 1, Moscow, Russia
International Journal of Civil Engineering and Technology (IJCIET) Volume 10, Issue 04, April 2019, pp. 1486 1494, Article ID: IJCIET_10_04_155 Available online at http://www.iaeme.com/ijmet/issues.asp?jtype=ijciet&vtype=10&itype=4
More informationFLIGHT SCHEDULE PUNCTUALITY CONTROL AND MANAGEMENT: A STOCHASTIC APPROACH
Transportation Planning and Technology, August 2003 Vol. 26, No. 4, pp. 313 330 FLIGHT SCHEDULE PUNCTUALITY CONTROL AND MANAGEMENT: A STOCHASTIC APPROACH CHENG-LUNG WU a and ROBERT E. CAVES b a Department
More informationScienceDirect. Prediction of Commercial Aircraft Price using the COC & Aircraft Design Factors
Available online at www.sciencedirect.com ScienceDirect Procedia Engineering 67 ( 2013 ) 70 77 7th Asian-Pacific Conference on Aerospace Technology and Science, 7th APCATS 2013 Prediction of Commercial
More informationREVISIONS IN THE SPANISH INTERNATIONAL VISITORS ARRIVALS STATISTICS
Revisions in the Spanish International Visitor Arrivals Statistics REVISIONS IN THE SPANISH INTERNATIONAL VISITORS ARRIVALS STATISTICS Carlos Romero Dexeus 1 Abstract: This article concerns the revision
More informationNAGARDO THE NATURAL GUARDIAN FOR BEVERAGE QUALITY NATURAL BEVERAGE PROTECTION
QUALITY GUARDS. Beverage manufacturers tailor beverages to meet their customers lifestyle at LANXESS we tailor the corresponding beverage protection. Nagardo is the natural guardian to secure and prolong
More informationCONGESTION MONITORING THE NEW ZEALAND EXPERIENCE. By Mike Curran, Manager Strategic Policy, Transit New Zealand
CONGESTION MONITORING THE NEW ZEALAND EXPERIENCE 26 th Australasian Transport Research Forum Wellington New Zealand 1-3 October 2003 By, Manager Strategic Policy, Transit New Zealand Abstract New Zealand
More informationMeasuring Productivity for Car Booking Solutions
Measuring Productivity for Car Booking Solutions Value Creation Study Rebecca Bartlett 20th January 2014 Table of Contents Executive Summary Introduction Method Productivity Analysis Scenario 1 Scenario
More informationStatistical Evaluation of BMP Effectiveness in Reducing Fecal Coliform Impairment in Mermentau River Basin
Statistical Evaluation of BMP Effectiveness in Reducing Fecal Coliform Impairment in Mermentau River Basin Z.-Q. Deng 1 and H. Chowdhary 2 1 Assistant Professor, Department of Civil and Environmental Engineering,
More informationDepeaking Optimization of Air Traffic Systems
Depeaking Optimization of Air Traffic Systems B.Stolz, T. Hanschke Technische Universität Clausthal, Institut für Mathematik, Erzstr. 1, 38678 Clausthal-Zellerfeld M. Frank, M. Mederer Deutsche Lufthansa
More informationAboriginal and Torres Strait Islander Life Expectancy and Mortality Trend Reporting to 2014
Aboriginal and Torres Strait Islander Life Expectancy and Mortality Trend Reporting to 2014 Technical Report June 2016 Authors: Clare Coleman, Nicola Fortune, Vanessa Lee, Kalinda Griffiths, Richard Madden
More informationPerth & Kinross Council. Community Planning Partnership Report June 2016
Perth & Kinross Council Community Planning Partnership Report June 2016 Contents Foreword... 3 Section 1: Spring 2016 destination follow up of 2014/15 school leavers... 4 Background... 4 Section A: Initial
More informationCamper Information. Street Address Apartment/Unit # City State ZIP Code. Parent/Guardian Information. Last First M.I. City State ZIP Code
Health History Form Parents / Guardians must complete all sections of this form apart from the final section which should be completed by the campers physician or a licensed medical personnel. Camper Information
More informationLAKE HURON BEACH STUDY
LAKE HURON BEACH STUDY A microbiological water quality evaluation of Grand Bend Beach and related pollution sources in 1985 Ministry of the Environment D.A. McTavish Director Southwestern Region Copyright
More informationTufts University Water: Systems, Science, and Society (WSSS) Program
To: From: John Foster, Elbow Cay, the Bahamas; Friends of the Environment, Marsh Harbor, the Bahamas Alex Bedig, Amanda Garfield, Shonda Gaylord, Jack Melcher, Melissa Ng, Nathan Rawding, Kendall Webster,
More informationWater Quality Trends for Patchogue Bay
Water Quality Trends for Patchogue Bay 2018 This report summarizes water quality data for fecal coliform and total coliform in Patchogue Bay for the years 2003-2017. Prepared by: Brian M. McCaffrey Stormwater
More informationSATELLITE CAPACITY DIMENSIONING FOR IN-FLIGHT INTERNET SERVICES IN THE NORTH ATLANTIC REGION
SATELLITE CAPACITY DIMENSIONING FOR IN-FLIGHT INTERNET SERVICES IN THE NORTH ATLANTIC REGION Lorenzo Battaglia, EADS Astrium Navigation & Constellations, Munich, Germany Lorenzo.Battaglia@Astrium.EADS.net
More informationIndividual Lab Report Ci-Trol Jun,2016. APTT (seconds) Ci-Trol 1 - Lot# Your Lab
Individual Lab Report Ci-Trol,2016 ST VINCENT MEDICAL CENTER LABORATORY(LAB# 7300 ) 2131 WEST THIRD STREET LOS ANGELES CA USA 90057 APTT (seconds) SYSMEX CA 1500-1, DADE ACTIN FSL Period SD CV # Points
More informationANA Traffic Growth Incentives Program Terms and Conditions
ANA Traffic Growth s Program Terms and Conditions 1. Introduction ANA Traffic Growth s Program (hereinafter referred to as the Program) is aimed at the growth of commercial air traffic at ANA airports
More informationTrail Use in the N.C. Museum of Art Park:
Trail Use in the N.C. Museum of Art Park: New Connections, New Visitors Jacqueline MacDonald Gibson, PhD Daniel Rodriguez, PhD Taylor Dennerlein, MSEE, MCRP, EIT Jill Mead, MPH Evan Comen University of
More informationEstablishing a Risk-Based Separation Standard for Unmanned Aircraft Self Separation
Establishing a Risk-Based Separation Standard for Unmanned Aircraft Self Separation Roland E. Weibel, Matthew W.M. Edwards, and Caroline S. Fernandes MIT Lincoln laboratory Surveillance Systems Group Ninth
More informationHow much did the airline industry recover since September 11, 2001?
Catalogue no. 51F0009XIE Research Paper How much did the airline industry recover since September 11, 2001? by Robert Masse Transportation Division Main Building, Room 1506, Ottawa, K1A 0T6 Telephone:
More informationMacon County, NC State of the County Health Report. Prepared by the Macon County Public Health Center & Healthy Carolinians of Macon County
Macon County, NC State of the County Health Report Prepared by the Macon County Public Health Center & Healthy Carolinians of Macon County What is the State Of The County Health Report (SOTCH)? Update
More informationCrown copyright Published with the permission of the Controller of Her Majesty s Stationery Office (HMSO). ISBN ISSN
(ONS) Introduction A report on the 2000 International Passenger Survey London: The Stationery Office 1 Introduction Crown copyright 2001. Published with the permission of the Controller of Her Majesty
More information3M Food Safety 3M Petrifilm Plates and Reader. Simply. Prompt. Precise. Productive.
3M Food Safety 3M Petrifilm Plates and Reader Simply Prompt. Precise. Productive. brilliant. This red dot changed microbiology. Imagine what it can do for your lab. In today s environment of heightened
More informationSTUDY OF EFFECTS OF VIBRATION ON GRIP STRENGTH
Vol.2, Issue.1, Jan-Feb 2012 pp-454-457 ISSN: 2249-6645 STUDY OF EFFECTS OF VIBRATION ON GRIP STRENGTH 1 Akhilesh.H.Gaidhane, 2 Dr S. G. Patil 1 (Reader Mech.engg.deptt, RSR RCET Raipur) 2 (Proff.Mech.Engg
More information3M Food Safety 3M Petrifilm Plates and 3M Petrifilm Plate Reader
3M Food Safety 3M Petrifilm Plates and 3M Petrifilm Plate Reader brilliant. This red dot changed microbiology. Imagine what it can do for your lab. In today s environment of heightened focus on food safety
More informationTourist Traffic in the City of Rijeka For the Period Between 2004 and 2014
Tourist Traffic in the City of Rijeka For the Period Between 2004 and 2014 Rijeka, February 2015. Table of Contents Pg No. 1. Introduction 3 2. Physical indicators on an annual level 4 2.1. Structure and
More informationEVALUATING THE IMPACT OF THE ECONOMIC CRISIS ON GREEK TOURISM: PUBLIC
EVALUATING THE IMPACT OF THE ECONOMIC CRISIS ON GREEK TOURISM: PUBLIC PERCEPTIONS AMONG ROMANIANS Ana Maria Tuluc Ph. D Student Academy of Economic Studies Faculty of Economics Bucharest, Romania Abstract:
More informationUC Berkeley Working Papers
UC Berkeley Working Papers Title The Value Of Runway Time Slots For Airlines Permalink https://escholarship.org/uc/item/69t9v6qb Authors Cao, Jia-ming Kanafani, Adib Publication Date 1997-05-01 escholarship.org
More informationHEATHROW COMMUNITY NOISE FORUM
HEATHROW COMMUNITY NOISE FORUM 3Villages flight path analysis report January 216 1 Contents 1. Executive summary 2. Introduction 3. Evolution of traffic from 25 to 215 4. Easterly departures 5. Westerly
More informationSHIP MANAGEMENT SURVEY. January June 2018
CENTRAL BANK OF CYPRUS EUROSYSTEM SHIP MANAGEMENT SURVEY January June 2018 INTRODUCTION The Ship Management Survey (SMS) is conducted by the Statistics Department of the Central Bank of Cyprus and concentrates
More informationGrip strength is associated with marksmanship and defensive tactics, but not injuries, in police recruits
Bond University epublications@bond Faculty of Health Sciences & Medicine Publications Faculty of Health Sciences & Medicine 10-17-2013 Grip strength is associated with marksmanship and defensive tactics,
More informationPathogens and Grazing Livestock
Pathogens and Grazing Livestock Steve Ensley DVM, PhD 10/16/09 Water Borne Pathogens This presentation will have a specific emphasis on water borne pathogens. NUMBERS OF IOWA WATER SOURCES WITH Stream/River
More informationISPUB.COM. Microbiological Quality Of Sweetmeat With Special Reference To Staphylococci. S Chakraborty, A Pramanik, A Goswami, R Ghosh, S Biswas
ISPUB.COM The Internet Journal of Microbiology Volume 1 Number 1 Microbiological Quality Of Sweetmeat With Special Reference To Staphylococci S Chakraborty, A Pramanik, A Goswami, R Ghosh, S Biswas Citation
More informationPackage leaflet: Information for the user. Levofloxacin 5 mg/ml eye drops solution. Levofloxacin (as hemihydrate)
Package leaflet: Information for the user Levofloxacin 5 mg/ml eye drops solution Levofloxacin (as hemihydrate) Read all of this leaflet carefully before you start taking this medicine because it contains
More informationBACTERIAL CONTAMINATION OF WATER WELLS AND SPRINGS
4/15/215 BACTERIAL CONTAMINATION OF WATER WELLS AND SPRINGS Bryan Swistock Water Resources Specialist Penn State Extension Department of Ecosystem Science and Management Microbiological Parameters Standard
More informationRestructuring of advanced instruction and training programs in order to increase the number of flight hours for military pilots.
Restructuring of advanced instruction and training programs in order to increase the number of flight hours for military pilots. Part II Ioan STEFANESCU* 1 *Corresponding author Aerospace Consulting B-dul
More informationA Study of Unclaimed Prescriptions in Hospital Universiti Sains Malaysia (HUSM)
, ORIGINAL ARTICLE A Study of Unclaimed Prescriptions in Hospital Universiti Sains Malaysia (HUSM) W S Kamaruzaman, MPH Department of Community Medicine, School of Medical Sciences, Universiti Sains Malaysia,
More informationTHE HOUSING SITUATION IN NUNAVIK: A PUBLIC HEALTH PRIORITY
THE HOUSING SITUATION IN NUNAVIK: A PUBLIC HEALTH PRIORITY by Serge Déry, MD, MSc, MPH, FRCPC, CSPQ Director of Public Health and Hamado Zoungrana Research agent Last update: December 2009 THE HOUSING
More informationARRIVAL CHARACTERISTICS OF PASSENGERS INTENDING TO USE PUBLIC TRANSPORT
ARRIVAL CHARACTERISTICS OF PASSENGERS INTENDING TO USE PUBLIC TRANSPORT Tiffany Lester, Darren Walton Opus International Consultants, Central Laboratories, Lower Hutt, New Zealand ABSTRACT A public transport
More informationA stated preference survey for airport choice modeling.
XI Riunione Scientifica Annuale -!Società Italiana di Economia dei Trasporti e della Logistica Trasporti, logistica e reti di imprese: competitività del sistema e ricadute sui territori locali, Trieste,
More informationProtecting Consumers. Improving lab efficiency. 3M Petrifilm Plates and Reader
Protecting Consumers. Improving lab efficiency. 3M Petrifilm Plates and Reader Simply brilliant. This red dot changed microbiology. Imagine what it can do for your lab. In today s environment of heightened
More informationNETWORK MANAGER - SISG SAFETY STUDY
NETWORK MANAGER - SISG SAFETY STUDY "Runway Incursion Serious Incidents & Accidents - SAFMAP analysis of - data sample" Edition Number Edition Validity Date :. : APRIL 7 Runway Incursion Serious Incidents
More informationPredicting a Dramatic Contraction in the 10-Year Passenger Demand
Predicting a Dramatic Contraction in the 10-Year Passenger Demand Daniel Y. Suh Megan S. Ryerson University of Pennsylvania 6/29/2018 8 th International Conference on Research in Air Transportation Outline
More informationInterim FDG-PET Visual interpretation vs. qpet
Interim FDG-PET Visual interpretation vs. qpet R. Kluge, D. Hasenclever, L. Kurch, L. Chavdarova, M. Hoffmann, C. Kobe, B. Malkowski, F. Montravers, C. Mauz-Körholz, T. Georgi, D. Körholz Paediatric Hodgkin
More informationStudy on Hotel Management Graduates Perceptions and Preferences of Jobs in Hotel Industry in Chennai City
Study on Hotel Management Graduates Perceptions and Preferences of Jobs in Hotel Industry in Chennai City T.S. Natarajan, Research scholar, Department of Management studies, SCSVMV University, India. E-mail:
More informationFrom Unconscious Incompetence to Conscious competence Learnings from a Legionella outbreak
From Unconscious Incompetence to Conscious competence Learnings from a Legionella outbreak Kathy Taylor Infection Control Manager The Wesley Hospital In the beginning.. St Helens Hospital at South Brisbane
More informationPeculiarities in the demand forecast for an HSRL connecting two countries. Case of Kuala Lumpur Singapore HSRL
València, Universitat Politècnica de València, 2016 DOI: http://dxdoiorg/104995/cit201620163458 Peculiarities in the demand forecast for an HSRL connecting two countries Case of Kuala Lumpur Singapore
More informationPetrofin Research Greek fleet statistics
Petrofin Research 2 nd part of Petrofin Research : Greek fleet statistics In this 2 nd part of Petrofin research, the Greek Fleet Statistics, we analyse the composition of the Greek fleet, in terms of
More informationSupplemental Information
Neuron, Volume 88 Supplemental Information Time-Resolved Imaging Reveals Heterogeneous Landscapes of Nanomolar Ca 2+ in Neurons and Astroglia Kaiyu Zheng, Lucie Bard, James P. Reynolds, Claire King, Thomas
More informationAnalyzing Risk at the FAA Flight Systems Laboratory
Analyzing Risk at the FAA Flight Systems Laboratory Presented to: Workshop By: Dr. Richard Greenhaw, FAA AFS-440 Date: 29 November, 2005 Flight Systems Laboratory Who we are How we analyze risk Airbus
More informationPr oject Summar y. Impact of ground beef packaging systems and temperature abuse on the safety of ground beef
Pr oject Summar y Impact of ground beef packaging systems and temperature abuse on the safety of ground beef Principal Investigators: J Chance Brooks, Mindy M. Brashears, Mark F. Miller, and Adam Tittor
More informationInfluence of the constructive features of rocket stoves in their overall efficiency
WISSENSCHAFTLICHE ARTIKEL 1 Influence of the constructive features of rocket stoves in their overall efficiency Sonia Rueda and Mónica Gutiérrez This contribution presents the results obtained from the
More informationProject Title Assessing postharvest food safety risks and identifying mitigation strategies for foodborne pathogens in pistachios
CPS 2013 RFP FINAL PROJECT REPORT Project Title Assessing postharvest food safety risks and identifying mitigation strategies for foodborne pathogens in pistachios Project Period January 1, 2014 December
More information1. Introduction. 2.2 Surface Movement Radar Data. 2.3 Determining Spot from Radar Data. 2. Data Sources and Processing. 2.1 SMAP and ODAP Data
1. Introduction The Electronic Navigation Research Institute (ENRI) is analysing surface movements at Tokyo International (Haneda) airport to create a simulation model that will be used to explore ways
More information